Mocetinostat
In human trialsMeasured in people, not heightBy mouthSmall molecule
An experimental cancer drug that blocks a set of enzymes controlling which genes a cell reads.
An orally available benzamide that inhibits HDAC1, 2, 3 and 11 — class I plus the class IV enzyme. Developed for cancer throughout, through more than twenty registered trials, and never approved anywhere. Its sponsor de-prioritised it, and two trials record termination for that reason rather than for safety.
Risks. Common fatigue and gut upset, with fluid around the heart in about one patient in ten.
On this page
- At the growth plate, members only
- Risks and side effects, members only
The rest of this page is for members
What has been measured, in whom, with every source, and what it does to the rest of you. And every article in the library.
Join for $11.99Lifetime · 3 of 10 founding spots left
Tax is added at checkout (VAT/GST where it applies).
Renews every month at the current price plus tax until you cancel. Cancel from your account before the next monthly charge to stop it.
Card purchases are sold and charged by Link (Stripe) under Link's terms and refund policy.
Already a member? Sign in
Educational content, not medical advice. Nothing here is a recommendation to take or stop taking anything — talk to a doctor about your own situation.